ArticleCancers2024

Circulating microRNAs as a Prognostic Tool to Determine Treatment Efficacy in Lung Cancer Patients Undergoing Pembrolizumab PD-1 Blockade Immunotherapy.

Mishfak A Mohamed Mansoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.